A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia (NCT07304089)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia (Stride Dystonia)
🩺 Plain-English Summary (8th-Grade Level)
Stride Dystonia is a randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of VIM0423 in individuals with isolated dystonia. The main objectives of this clinical trial are to determine the following: * Does VIM0423 therapy improve dystonia symptoms compared to placebo? * Is VIM0423 well tolerated in individuals with isolated dystonia? and * Do the therapeutic effects of VIM0423 confer improvements on daily function and quality of life?
Who can join: Review the eligibility criteria below.
Location: Vima Site #033 — Birmingham, Alabama
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (37 Sites)
Showing the first 25 of 37 sites.
- Vima Site #033 — Birmingham, Alabama
- Vima Site #039 — Scottsdale, Arizona
- Vima Site #004 — Scottsdale, Arizona
- Vima Site #028 — Sun City, Arizona
- Vima Site #042 — Irvine, California
- Vima Site #030 — Los Angeles, California
- Vima Site #019 — Denver, Colorado
- Vima Site #009 — Gainesville, Florida
- Vima Site #008 — Miami, Florida
- Vima Site #031 — Orlando, Florida
- Vima Site #005 — Atlanta, Georgia
- Vima Site #027 — Chicago, Illinois
- Vima Site #041 — Overland Park, Kansas
- Vima Site #043 — Baltimore, Maryland
- Vima Site #007 — Olney, Maryland
- Vima Site #032 — Boston, Massachusetts
- Vima Site #037 — East Lansing, Michigan
- Vima Site #002 — Farmington Hills, Michigan
- Vima Site #038 — St Louis, Missouri
- Vima Site #014 — Albuquerque, New Mexico
- Vima Site #018 — New York, New York
- Vima Site #024 — New York, New York
- Vima Site #036 — Rochester, New York
- Vima Site #040 — Fayetteville, North Carolina
- Vima Site #035 — Cincinnati, Ohio
📞 Contact the Study Coordinator
Phone: (617) 430-7027
Email: Clinicaltrials@vimatx.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Dystonia
- Deep Brain Stimulation Surgery for Focal Hand Dystonia — Bethesda, Maryland
- Studies of the Variable Phenotypic Presentations of Rapid-Onset Dystonia Parkinsonism and Other Movement Disorders — Miami, Florida
- Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia — Boston, Massachusetts
- Effects of Exercise on Dystonia Pathophysiology — Gainesville, Florida
- Vercise™ DBS Dystonia Prospective Study — Ghent,
- Dystonia Genotype-Phenotype Correlation — Dallas, Texas
Explore by condition: All Dystonia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.